Who owns the LEROCHOL trademark?

The LEROCHOL trademark is owned by LIB THERAPEUTICS, INC..

What class is the LEROCHOL trademark registered in?

The LEROCHOL trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for LEROCHOL?

The USPTO serial number for LEROCHOL is 98186146.

What is the registration number for LEROCHOL?

LEROCHOL is registered under USPTO registration number 8111583.

Sealvo

Home Search: LEROCHOLLEROCHOL #98186146

Back

Updated Sep 23, 2026·22 searches this week

View on USPTO TSDR Find similar marks

LER

USPTO Trademark Record

REGISTERED

LEROCHOL

SN 98186146·Reg 8111583·Filed Sep 19, 2023

Owner LIB THERAPEUTICS, INC.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

LEROCHOL (Serial No. 98186146), Registration No. 8111583, is a registered US trademark filed on Sep 19, 2023 by LIB THERAPEUTICS, INC.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: January 20, 2032

Conflict Analysis

Full conflict analysis for LEROCHOL (SN 98186146) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

LEROCHOL (Reg. #8111583) is a registered US trademark that has been protecting its owner, LIB THERAPEUTICS, INC., since 2023. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 19, 2023

SERIAL

98186146

REG#

8111583

REGISTERED

Jan 20, 2026

Filing Information

StatusREGISTERED

Filing DateSep 19, 2023

Serial Number98186146

Registration No.8111583

Registration DateJan 20, 2026

Status DateJan 20, 2026

Published for OppositionJun 18, 2024

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Sep 30, 2024

First use in commerce: Sep 30, 2024

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

27 events

REGISTERED-PRINCIPAL REGISTER

Jan 20, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jan 20, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Dec 30, 2025

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Dec 30, 2025

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Dec 01, 2025

STATEMENT OF USE PROCESSING COMPLETE

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Aug 13, 2025

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Aug 13, 2025

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Aug 13, 2025

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

TEAS STATEMENT OF USE RECEIVED

Jul 10, 2025

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Jul 10, 2025

USE AMENDMENT FILED

SOU TEAS EXTENSION RECEIVED

Jul 08, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Jul 08, 2025

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Jul 08, 2025

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jul 08, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 03, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Jan 06, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Jan 06, 2025

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Jan 06, 2025

SOU EXTENSION 1 GRANTED

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Dec 25, 2024

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Aug 13, 2024

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jun 18, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 18, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 29, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 15, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

May 13, 2024

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 04, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Sep 21, 2023

NEW APPLICATION ENTERED

Other Marks by LIB THERAPEUTICS, INC.

Additional USPTO filings from the same owner.

LER

LEROCHOL DIRECT

99874431

LIB Therapeutics, Inc.

PENDING

LIB

LIBERATE

99431914

LIB Therapeutics, Inc.

PENDING

LIB

LIBRECOR

98655261

LIB THERAPEUTICS, INC.

PENDING

LIB

LIBRECOL

98655267

LIB THERAPEUTICS, INC.

PENDING

Other Marks by Michael A. Marrero

Additional USPTO filings handled by the same attorney of record.

VIA

VIATOR

74615953

REGISTERED

CON

CONSEP2000

75127135

REGISTERED

ATM

ATMYS

99189584

REGISTERED

EQU

EQUITY ENTERPRISE SOLUTIONS

99564335

REGISTERED

LEROCHOL

Run a conflict check

Other Marks by LIB THERAPEUTICS, INC.

Other Marks by Michael A. Marrero

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company